|
Originally published In Press as doi:10.1074/jbc.M205386200 on August 28, 2002
J. Biol. Chem., Vol. 277, Issue 45, 43399-43409, November 8, 2002
Proteomic Analysis of a Detergent-resistant Membrane Skeleton
from Neutrophil Plasma Membranes*,
Thomas
Nebl ,
Kersi N.
Pestonjamasp §,
John D.
Leszyk¶,
Jessica L.
Crowley ,
Sang W.
Oh , and
Elizabeth J.
Luna
From the Department of Cell Biology, University of
Massachusetts Medical School, Worcester, Massachusetts 01605 and
¶ Proteomic Mass Spectrometry Laboratory, University of
Massachusetts Medical School, Shrewsbury, Massachusetts 01545
Received for publication, May 31, 2002, and in revised form, August 26, 2002
 |
ABSTRACT |
Plasma membranes are organized into functional
domains both by liquid-ordered packing into "lipid rafts,"
structures that resist Triton extraction, and by attachments to
underlying cytoskeletal proteins in assemblies called "membrane
skeletons." Although the actin cytoskeleton is implicated in many
lipid raft-mediated signaling processes, little is known about the
biochemical basis for actin involvement. We show here that a subset of
plasma membrane skeleton proteins from bovine neutrophils co-isolates
with cholesterol-rich, detergent-resistant membrane fragments (DRMs)
that exhibit a relatively high buoyant density in sucrose (DRM-H;
d ~1.16 g/ml). By using matrix-assisted laser
desorption/ionization time of flight and tandem mass spectrometry, we
identified 19 major DRM-H proteins. Membrane skeleton proteins include
fodrin (nonerythroid spectrin), myosin-IIA, myosin-IG, -actinin 1, -actinin 4, vimentin, and the F-actin-binding protein, supervillin.
Other DRM-H components include lipid raft-associated integral membrane
proteins (stomatin, flotillin 1, and flotillin 2), extracellular
surface-bound and glycophosphatidylinositol-anchored proteins (IgM,
membrane-type 6 matrix metalloproteinase), and intracellular dually
acylated signaling proteins (Lyn kinase, G i-2).
Consistent with cytoskeletal association, most DRM-H-associated
flotillin 2, Lyn, and G i-2 also resist extraction with
0.1 M octyl glucoside. Supervillin, myosin-IG, and
myosin-IIA resist extraction with 0.1 M sodium carbonate, a
treatment that removes all detectable actin, suggesting that these
cytoskeletal proteins are proximal to the DRM-H bilayer. Binding of
supervillin to the DRM-H fragments is confirmed by co-immunoaffinity
purification. In spreading neutrophils, supervillin localizes with
F-actin in cell extensions and in discrete basal puncta that partially
overlap with G i staining. We suggest that the DRM-H
fraction represents a membrane skeleton-associated subset of leukocyte
signaling domains.
 |
INTRODUCTION |
Plasma membranes in eukaryotic cells are organized into domains of
specialized function. Many of these domains are relatively stable on
the cell surface and involve a series of linkages between cytoplasmic
cytoskeletal proteins, integral membrane proteins, and extracellular
attachments to the substrate or to other cells. For example,
intermediate filament anchorages to membranes at desmosomes and
hemidesmosomes distribute mechanical stresses over epithelial surfaces
and maintain the integrity of skin and other tissues (1, 2). Plasma
membrane domains anchored to actin filaments include spectrin-based
meshworks, adsorptive cell surface microvilli, focal adhesions, and
adherens junctions (3-7). In each of these domains, interactions
between cytoskeletal proteins provide resistance against disruption by
nonionic detergents, such as Triton X-100 and octyl glucoside,
permitting the transmembrane protein assembly to be isolated as a
"membrane skeleton" (8).
Lipid-lipid interactions also can organize membranes into
detergent-resistant domains. Such lipid "rafts" are stabilized
against disruption by cold Triton X-100 through liquid-ordered packing of component cholesterol, (glyco)sphingolipids, and gel-phase glycerolipids (9, 10). Lipid rafts contain resident integral membrane
proteins, such as caveolin, stomatin, and flotillin (11), extracellular
proteins with glycophosphatidylinositol (GPI) anchors containing long
chain fatty acids (12), and cytoplasmic proteins modified by a dual
myristoylation/palmitoylation motif or by palmitoylation on two or more
cysteine residues (13-15). When analyzed in vivo by
spectroscopic methods, plasma membrane lipid rafts consist of clusters
of ~20 proteins and ~3500 sphingolipid molecules and are ~50 nm
in diameter, a size well below the resolution limit of light microscopy
(16, 17). These dimensions can be increased into the submicron to
micron range through aggregation of raft components, e.g. by
receptor activation or addition of bivalent antibodies against
raft-associated surface antigens (18-20). After treatment of cells or
membranes with cold Triton X-100, the coalescing detergent-resistant
remnants of the lipid rafts are called detergent-resistant membranes
(DRMs).1 DRMs, which
represent a subset of the endogenous raft lipids and proteins (21), can
be recovered by flotation into low density fractions (DRM-L) from
sucrose or OptiprepTM gradients (19).
Both cytoskeleton-stabilized membrane domains and lipid rafts provide
sites at which localized signal transduction can occur (3, 8, 19).
Selective recruitment of proteins from the cytoplasm or protein
diffusion within the plane of the membrane can regulate signaling
events, such as those downstream of growth factor addition, ion channel
activation, or changes in cell adhesion. Because many signaling
proteins, including heterotrimeric G proteins and members of the Src
family of protein tyrosine kinases, are dually acylated, lipid rafts
have been proposed as platforms for the controlled interaction of
substrates and signaling enzymes (19, 22). Lipid rafts also have been
proposed to play roles in membrane targeting and endocytotic
trafficking (23). Cascades of recruitment of adaptor proteins and
kinases to lipid rafts are well characterized during receptor
activation in B lymphocytes, T lymphocytes, and mast cells (19).
Compartmentalized signaling at lipid rafts may be especially important
for hematopoietic cells, which form dynamic attachments to substrates
and other cells and lack many types of stable cell surface adhesions.
Although signaling downstream of lipid raft-associated adhesive stimuli
requires filamentous actin (24, 25), the role of F-actin in this
process is unknown.
F-actin is known to be an important structural and functional component
of plasma membranes from mammalian neutrophils (26). Neutrophils are
the most abundant of the circulating leukocytes and are readily
available in large quantities from bovine blood (27-29). They are
terminally differentiated granulocytes that constitute the body's
first line of defense against invading microbes (30). In response to
chemotactic stimuli from pathogens or from other immune cells and/or
mucosal cells, neutrophils rapidly migrate across capillary endothelia
into body tissues (31). They engulf microbes coated with complement
proteins and/or immunoglobulins and kill the ingested microorganisms by
releasing proteases, antimicrobial proteins, and oxygen metabolites
into phagolysosomal compartments. Although polarity is maintained by
cytoplasmic microtubules (32), actin function in the membrane skeleton
and/or cortical cytoskeleton is required for chemotactic signaling,
cell movement, adhesion, and phagocytosis (33).
Despite its importance in early immune defense, the neutrophil membrane
skeleton is largely uncharacterized. In agreement with previous
observations of a spectrin-, actin-, and band 4.1-containing membrane
skeleton in neutrophils (34, 35), we have shown that a macromolecular
complex containing fodrin (non-erythrocyte spectrin), actin, and
non-muscle myosin-IIA exists in bovine neutrophil plasma membranes (28,
36). We also have used F-actin blot overlays and immunoblotting to show
that neutrophil plasma membranes contain ezrin, moesin, and a 205-kDa
F-actin-binding protein that we named supervillin. Molecular cloning of
supervillin cDNA indicated that this protein contains a carboxyl
terminus with predicted similarities to villin and a novel amino
terminus (36, 37). The supervillin amino terminus contains functional
nuclear targeting signals, sites for direct binding to F-actin, and
regions that promote actin filament binding and bundling (38).
Supervillin is a tightly bound peripheral membrane protein that is
concentrated at sites of epithelial cell-cell adhesion (36). This
protein also has been reported to be a minor constituent of lipid rafts
from detergent-solubilized Jurkat T cells (39) and to co-purify with
P2X7 ATP receptors from embryonic kidney cells (40).
Supervillin message levels are elevated in neutrophils stimulated with
lipopolysaccharide from gingivitis-causing bacteria (41), implying a
role during physiological activation of neutrophils.
 |
EXPERIMENTAL PROCEDURES |
Reagents and Antibodies--
The protease inhibitors,
4-(2-aminoethyl)benzenesulfonyl fluoride, leupeptin, and bestatin,
were purchased from Calbiochem-Novabiochem. Density gradient
centrifugation media, PercollTM and OptiprepTM,
were from Amersham Biosciences and Nycomed Pharma AS (Oslo, NOR),
respectively. Tosyl-activated or protein A-conjugated Dynabeads M-280
were from Dynal Inc. (Lake Success, NY). Nonspecific control rabbit IgG
and mouse monoclonal primary antibodies against -actinin, -actin,
and vimentin were purchased from Sigma. Monoclonal anti-Lyn and
anti-G i-2 antibodies were from Santa Cruz Biotechnology
(Santa Cruz, CA). Monoclonal anti-flotillin 2 was from BD Biosciences; monoclonal anti- -fodrin was from ICN Biomedicals Inc. (Aurora, OH),
and polyclonal rabbit anti-non-muscle myosin-II IgG was from Biomedical
Technologies Inc. (Stoughton, MA).
Myosin-IG was stained by a monoclonal antibody raised against chicken
brush-border myosin (myosin-IA) that recognizes the head domain of
multiple myosin-I isoforms (42, 43) and also by affinity-purified
rabbit IgG against a consensus myosin-IA peptide (G-371) (44). These
antibodies were the kind gifts of Dr. Mark Mooseker (Yale University,
New Haven, CT) and Dr. Martin Bähler (Westfälische
Wilhelms-Universität, Münster, Germany), respectively.
Horseradish peroxidase (HRP)-conjugated sheep IgG against bovine IgM
was from Serotech Ltd. (Oxford, UK). HRP-conjugated, as well as
alkaline phosphatase-conjugated, goat anti-rabbit IgG and goat
anti-mouse IgG were purchased from Jackson ImmunoResearch. AlexaFluor
488 goat F(ab')2 anti-rabbit IgG and AlexaFluor 568 goat
F(ab')2 anti-mouse IgG were purchased from Molecular Probes (Eugene, OR). All other chemicals were purchased from Sigma.
Affinity-purified Anti-supervillin IgG--
The HSV41 clone
(37) containing human supervillin cDNA sequences
(GenBankTM accession number AF051851) was
digested with EcoRI and NotI and ligated into the
pGEMEX-1 vector (Promega Corp., Madison, WI). A chimeric fusion protein
consisting of 260 amino acids of T7 gene 10 and linker sequence plus
the first 340 amino acids of human supervillin (H340) was expressed in
BL21(DE3) bacteria after induction with isopropyl
-D-thiogalactopyranoside. The fusion protein was
purified as inclusion bodies and used as an immunogen for the
production of rabbit polyclonal antisera (Research Genetics,
Huntsville, AL). Antibodies against the amino-terminal 340 amino acids
of human supervillin ( H340) were affinity-purified against a
chimeric fusion protein of H340 and glutathione
S-transferase (GST). The GST-H340 protein was expressed in
bacteria from sequences encoded by the pGEX-6P-1 vector and HSV41
cDNA and was purified on glutathione-SepharoseTM, as
described by the manufacturer (Amersham Biosciences). All manipulations
were carried out at 4 °C, unless stated otherwise. Purified GST-H340
(~12 mg) was dialyzed against 20 mM sodium phosphate buffer (pH 7.6) and coupled to ~1.5 ml of CNBr-activated Sepharose 6MB (Sigma) for 24 h. The column was blocked with 0.2 M glycine ethyl ester (pH 8.0) for 24 h, washed with
40 ml of sodium phosphate buffer (pH 7.6), 2 ml of 4.5 M
MgCl2, 10 ml TBS (25 mM Tris-HCl, 1 mM EDTA (pH 7.4)), and stored in TBS containing 0.1%
thimerosal. The GST-H340 Sepharose beads were rotated overnight with
10-ml aliquots of specific rabbit antisera and washed sequentially at room temperature with the following: 1) ~150 ml TBS; 2) 6 ml of 1 M NaCl in TBS; 3) 4 ml of 2 M urea in TBS; and
4) 2 ml of 10 mM Tris-HCl (pH 7.5). High affinity
antibodies were eluted with 4.5 M MgCl2, 72.5 mM Tris (pH 7.0) and collected in 1-ml fractions with
equivalent volumes of 10 mM Tris-HCl (pH 7.5). Fractions containing affinity-purified IgG were pooled, repeatedly diluted with
10 mM Tris-HCl (pH 7.5), and re-concentrated to ~0.3 ml
by centrifugation at 2000 × g using
Ultra-Free-10TM ultrafiltrate concentrators (Millipore
Corp., Bedford, MA). Concentrated antibody was clarified by
centrifugation at 13,000 × g for 5 min and stored in
aliquots at 20 °C with ~1 mg/ml bovine serum albumin and 50%
(v/v) sterile glycerol. The specificity of H340 antibody was
confirmed by immunoblots of whole neutrophil extracts (Fig. 1A), and the suitability for staining of
paraformaldehyde-fixed samples was demonstrated using immunolabeling
experiments with COS-7 cells expressing a GFP-tagged bovine supervillin
(not shown). H340 antigen was purified by cleavage from GST-H340 and
chromatography on glutathioneTM-Sepharose and
DEAE-Sepharose, as recommended by the manufacturer (Amersham Biosciences).
Neutrophil Isolation--
Polymorphonuclear leukocytes were
routinely isolated from 8-10 liters of bovine blood provided by
Research 87 Inc. (Marlborough, MA). Peripheral blood was collected from
a single animal, immediately mixed 9:1 (v/v) with anti-coagulant
solution (3.8% (w/v) sodium citrate, 2.5 mM EDTA, 50,000 units of heparin), and stored on ice overnight. Neutrophils (~95%
pure) were obtained by hypo-osmotic lysis of erythrocytes, followed by
fractionation on preformed gradients of isotonic PercollTM
(27, 28, 45). Cells were washed twice and resuspended in Hanks'
deficient saline solution buffered with 10 mM HEPES (pH 7.4) (HBSS). All manipulations were carried out at 4 °C.
Neutrophil Plasma Membranes--
Neutrophils were treated with 5 mM diisopropylphosphofluoridate for 15 min,
washed, and resuspended in relaxation buffer (28) (10 mM
PIPES, 100 mM KCl, 3 mM NaCl, 3.5 mM MgCl2, 1 mM ATP, 1 mM EGTA, pH 7.3) containing a mix of protease inhibitors (1 mM phenylmethylsulfonyl fluoride, 0.4 µM
aprotinin, 10 µM E-64, 20 µM leupeptin, 10 µM bestatin, 5 µM
N-acetyl-Leu-Leu-Met-al, 2 µM pepstatin), and
disrupted by nitrogen cavitation. All manipulations were carried out at
0-4 °C. Cavitates were centrifuged at 1000 × g for
10 min to remove nuclei, and 10-ml aliquots of postnuclear supernatant
were loaded onto 28 ml of 1.06 g/ml PercollTM suspension in
relaxation buffer. Initially, plasma membranes were separated from
secretory vesicles, granules, and cytosol using PercollTM
step gradients, as described previously (28, 36). As a faster alternative to manual pipetting, PercollTM density
gradients were generated by centrifugation. Density gradients were
generated by centrifugation at 50,000 × g for 30 min
in a Beckman VTi50 vertical rotor. Neutrophil plasma membranes
corresponded to the " fraction" (~1.04 g/ml) from these
gradients. This fraction was enriched ~10-fold in cell surface (28)
and plasma membrane (27, 45) markers. After centrifugation at
140,000 × g for 2 h to remove residual
PercollTM particles, plasma membranes were resuspended in
relaxation buffer containing protease inhibitors, disrupted with 10-20
strokes of a tight-fitting Teflon Dounce homogenizer, and stored in
aliquots at 80 °C.
Immunofluorescence Microscopy--
Neutrophils suspended in HBSS
were seeded onto coverslips that were coated with
poly-L-lysine or zymosan-activated plasma for 15 min at
22 °C (28). Zymosan-activated plasma was prepared by incubating
bovine plasma (from the same batch of peripheral blood used to isolate
the neutrophils) with 5 mg/ml zymosan at 37 °C for 60 min and
clarified by centrifugation at 100,000 × g for 60 min.
Non-adherent cells were removed, and adherent unactivated (poly-L-lysine) or activated (zymosan-activated plasma)
cells were incubated at 37 °C in 5% CO2 for 30-60 min
in 10 mM potassium phosphate, 130 mM NaCl, 0.6 mM CaCl2, 1 mM MgCl2,
2.7 mM KCl, 0.18% glucose, pH 7.4. Neutrophils were fixed
with 4% paraformaldehyde in PBS (pH 7.4) for 10 min, washed three
times in PBS, and then permeabilized using 0.5% Triton X-100 for 10 min at 22 °C. Exposed cytoplasmic surfaces of neutrophil plasma
membranes were obtained by disrupting cells with a focused jet of 60 mM PIPES, 25 mM HEPES, 10 mM EGTA,
2 mM MgCl2 (pH 6.9) (28, 46), delivered from a syringe with a 26-gauge needle at an oblique angle across the surface
of the coverslip. Sheared cells were immediately fixed in 2%
paraformaldehyde in the same buffer for ~15 min at 22 °C. Fixed
samples were washed 3 times for 5 min in PBS and blocked at 4 °C
overnight, or for up to 3 days, with 10% bovine serum, 0.02% sodium
azide, 0.02% thimerosal in PBS (pH 7.4). Samples then were incubated
2-4 h with 3 µg/ml affinity-purified H340 or nonspecific rabbit
IgG alone or together with mouse monoclonal anti-G i-2
antibody at 2 µg/ml in blocking solution. As an additional specificity control, aliquots of affinity-purified H340 were incubated for 2 h with 10 µg/ml purified H340 antigen before
addition to coverslips. After three washes in PBS, samples were
incubated with blocking solution containing 2 µg/ml AlexaFluor
488-labeled F(ab')2 fragment of goat anti-rabbit IgG and
either 2 µg/ml AlexaFluor 568-labeled F(ab')2 fragment of
goat anti-mouse IgG or 50 nM rhodamine phalloidin. At these
antibody concentrations, no significant background was observed in the
absence of primary antibody (not shown). After final washes, samples
were mounted with VectaShieldTM mounting medium (Vector
Laboratories Inc., Burlingame, CA) and observed using an MC100 Axioskop
epifluorescence microscope with filters for Texas Red and fluorescein
(Carl Zeiss Inc., Thornwood, NY). Phase contrast and fluorescence
micrographs were acquired with a model Retiga-1300 QImaging Camera and
processed using Openlab imaging software (Improvision Inc., Lexington,
MA). Confocal immunofluorescence images were recorded on a Bio-Rad MRC
1024 laser scanning confocal microscope equipped with a krypton/argon
laser and LaserSharp version 3.2 software (Bio-Rad). No bleed-through
fluorescence between different channels was detected in double-label experiments.
Detergent-resistant Membranes--
Detergent-resistant membranes
were prepared as shown (Fig. 2A and Fig. 3A).
Pelleted neutrophil plasma membranes (Fig. 3A, fraction 1)
were resuspended to 1-2 mg of membrane protein per ml of Triton X-100
extraction buffer (TEB: 1% Triton X-100, 25 mM Tris, 250 mM NaCl, 2.5 mM MgCl2, 1 mM EGTA, 1 mM ATP) containing protease
inhibitors and were incubated for 60 min on ice. Samples (6 × 2.7 ml) were underlayered with 0.3 ml of 48% (v/v) OptiprepTM
in TEB and centrifuged at 100,000 × g for 60 min at
4 °C in a Beckman TLA 100.3 rotor. Supernatant was discarded. The
sharp opalescent band at the top of the OptiprepTM cushion,
which represented the Triton X-100 extracted plasma membranes (Fig.
3A, fraction 2), was collected and adjusted to 30% (v/v)
with TEB and/or 60% OptiprepTM. Centrifugation of aliquots
(8 × 500 µl) at 350,000 × g for 2 h at
4 °C in a Beckman TLA120.1 rotor generated gradients of
OptiprepTM with detergent-resistant membrane fragments
(DRMs) floating at low buoyant density (Fig. 2A). Fractions
(50 µl) were collected and analyzed for total protein concentration
using BCA assay reagent (Pierce), for total cholesterol concentration
using Infinity cholesterol assay reagent (Sigma), and for refractive
indices using a model 334610 refractometer (Bausch & Lomb, Rochester,
NY), according to manufacturer's instructions. Cholesterol-rich DRM
fractions were then pooled (total DRMs; Fig. 3A,
fraction 4), mixed with an equal volume of TEB, and centrifuged
into linear 20-45% (w/v) sucrose density gradients at
200,000 × g for 18 h at 4 °C in a Beckman SW50.1 rotor. Single gradients were fractionated (300 µl) at
a rate of 0.5 ml/min using a model 640 density gradient fractionator
(Isco Inc., Lincoln, NE). Aliquots were assayed for total protein and
density and analyzed by SDS-PAGE, silver staining, and Western
blotting, as described in the figure legends. Fractions containing
lighter (DRM-L, d ~1.09-1.13 g/ml; Fig. 3A,
fraction 5) and denser (DRM-H, d ~1.15-1.18
g/ml; Fig. 3A, fraction 6) DRMs were identified,
pooled, and stored at 80 °C until use.
Electron Microscopy--
Transmission electron microscopy of
plasma membrane thin sections was carried out as detailed earlier (36).
Negative staining of the DRM-H fraction was performed according to
published methods (47), with minor modifications. Briefly, DRM-H
fractions were deposited onto EM grids that had been coated with carbon
and glow-discharged on the day of the experiment. Samples were allowed
to adhere for 30-60 s and stained for 30 s with 2%
OsO4 in 0.1 M cacodylate buffer (pH 7.4) and
for 30 s with 2% uranyl acetate in PBS (pH 7.4). After each
treatment, grids were rinsed with 6-10 drops of PBS and drained using
filter paper. Stained samples were air-dried and examined on a model
EM-301 transmission electron microscope (Philips Electron Optics Inc.,
Rahway, NJ) at an accelerating voltage of 60 kV.
Octyl Glucoside and Sodium Carbonate Extractions--
DRM-H
preparations (600 µg) were diluted 1:1 with relaxation buffer and
pelleted by ultracentrifugation (100,000 × g, 60 min, 4 °C) using a Beckman TLA120.2 rotor. Pellets (100 µg) were
resuspended in 200 µl of TEB, or 0.1 M octyl glucoside
extraction buffer (0.1 M octyl glucoside, 25 mM
Tris, 250 mM NaCl, 2.5 mM MgCl2, 1 mM EGTA, 1 mM ATP), or 0.1 M
Na2CO3 and extracted for 60 min on ice. As a
positive control, the pellet was completely solubilized by incubation
in 200 µl of SDS at 70 °C for 15 min. Samples were then
re-centrifuged as above using a Beckman TLA120.1 rotor, and the pellets
were resuspended to 200 µl with TEB. Both supernatants (S) and
resuspended pellets (P) were adjusted to final concentrations of 1%
Triton X-100, 250 mM NaCl, 50 mM Tris-HCl (pH
7.5). Volumes equivalent to 100 µl of the initial assay mixture were
analyzed by SDS-PAGE, silver staining, and Western blotting.
Gel Electrophoresis and Immunoblotting--
Protein or volume
equivalents of OptiprepTM/sucrose density gradient
fractions or DRM-H isolates/extracts were separated at 4 °C on high
resolution 100 × 140 × 1.5-mm 5-15% gradient
polyacrylamide SDS gels (48). Coomassie Blue and silver staining were
performed according to standard protocols (49). Molecular mass
standards were prestained full range Rainbow markers (Amersham
Biosciences). Separated proteins were documented by digitally scanning
gels using a model GS-700 imaging densitometer (Bio-Rad). For
immunoblotting, gels were electrotransferred to nitrocellulose
membranes (Schleicher & Schuell) at 4 °C. Blots were 1) blocked with
5% (w/v) nonfat dry milk in TBST (TBS containing 0.05% Tween 20) for
60 min, 2) incubated with the appropriate antibody for 2-4 h in this
blocking solution, 3) washed 3 times for 5 min in TBST, 4) incubated
for 1-2 h with alkaline phosphatase- or HRP-conjugated goat
anti-rabbit or anti-mouse IgG in blocking solution, 5) washed 3 times
for 5 min in TBST, and 6) visualized with BCIP/NBT Membrane Phosphatase Substrate (Kirkegaard & Perry Laboratories, Gaithersburg, MD) or
RenaissanceTM Western blot Chemiluminescence Reagent Plus
(PerkinElmer Life Sciences), as appropriate. Results were quantified
after exposure to BioMax MR Scientific Imaging Film (Eastman Kodak Co.)
and/or digitally scanned, as above.
MALDI-TOF and MS/MS via MALDI Post Source
Decay--
For identification of DRM-H associated proteins, protein
bands were excised from Coomassie Blue-stained gels with clean razor blades. Gel pieces (~1.5 × 1.5 × 6 mm) were rinsed 3 times for 5 min in deionized water. In-gel tryptic digests were
performed according to published protocols (50) with minor
modifications, e.g. the addition of 0.01%
n-octyl glucopyranoside in the digest buffer. Peptide
digests were concentrated using ZipTip C18 micropipette tips (Millipore
Corp.) according to recommended protocols, with the exception that the
ion-pairing agent trifluoroacetic acid was replaced by 1% formic acid.
MALDI-TOF and Post-Source-Decay (PSD) data were obtained on an
AXIMA-CFR mass spectrometer using software version 2.0.1 (Kratos
Analytical, Manchester, UK). Typically, mass spectrometric spectra were
obtained at a laser power near threshold with pulsed extraction
optimized for 2,000 Da; mass resolutions varied from 6,000 to 9,000 across the tryptic peptide mass range. PSD data were obtained at a
laser power ~15% higher than threshold. Samples were co-crystallized
with -cyano-4-hydroxycinnamic acid (10 mg/ml in 1% formic acid,
50% acetonitrile) via the dried drop method. External calibration in
MS mode was accomplished by a 3-point peptide mixture that covered the
mass range typical of tryptic digests (600-2,500 Da) and spotted
locally to the sample of interest. PSD fragment ions were fitted to a
generated curve, which was calibrated with PSD fragments from the
synthetic peptide, P14R. Data base searches were performed
using Protein Prospector version 3.4.1 (prospector.ucsf.edu).
Monoisotopic peptide masses were searched against the NCBI nonredundant
data base using the MS-Fit program and 50-100 ppm mass tolerances. PSD
fragments were searched against the NCBI nonredundant data base using
MS-Tag and 0.2 Da as the parent tolerance and 0.5 Da as the fragment ion tolerance.
Immunoaffinity Purification--
Preparative immunoisolations of
supervillin DRM complexes were performed as described previously (36)
and confirmed by analytical scale experiments, using M280
tosyl-activated or protein A-conjugated Dynabeads. Affinity-purified
rabbit H340 IgG and nonspecific control rabbit IgG (0.5-mg aliquots)
in PBS (pH 7.5) were coupled to washed Dynabeads by end-over-end
rotation overnight at 37 °C (tosyl-activated) or 4 °C (protein
A-conjugated). Protein A-bound IgG was cross-linked using 20 mM dimethylpimelimidate in 0.2 M sodium borate
(pH 8.5) for 45 min at room temperature. Unreacted sites on protein
beads were blocked in 0.2 M glycine ethyl ester (pH 8.2)
overnight at 4 °C. Cross-linked antibody beads were washed 3 times
for 10 min in borate buffer (pH 8.2), 1 time for 10 min in 0.1 M sodium acetate (pH 4.5), and 3 times for 10 min in TEB (pH 7.4). In analytical experiments, aliquots of neutrophil plasma membranes (250 µg of protein) were incubated for 1 h at 4 °C
in 0.5 ml of extraction buffer containing 1% Triton X-100 or 0.1 M octyl glucoside. The resulting detergent extracts were
incubated for an additional 4 h at 4 °C with Dynabeads
(~5 × 107 beads/tube) containing covalently bound
supervillin-specific H340 or nonspecific rabbit IgG plus 1% bovine
serum albumin (for silver staining) or 5% goat serum (for immunoblot
analyses). Unbound material, including bovine serum albumin and goat
serum proteins, was removed by washing the beads 3 times for 10 min in
extraction buffer with 1% Triton X-100 or 0.1 M octyl
glucoside, respectively. Immunoadsorbed material was magnetically
separated, eluted in SDS sample buffer at 70 °C for 10 min, and
analyzed by SDS-PAGE, silver staining, and immunoblotting.
 |
RESULTS |
Neutrophil Membrane Actin and Supervillin--
By using the
H340 antibody specific for supervillin (Fig.
1A), supervillin was
co-localized with actin filaments at the peripheries of adherent
neutrophils (Fig. 1B, e-h). Most unactivated
neutrophils appeared round and roughly symmetrical, with evenly
distributed cortical F-actin and supervillin (not shown). Activated
neutrophils exhibited a spread, polarized morphology with supervillin
and F-actin accumulations in ruffles and membrane protrusions (Fig. 1B, a-h). To examine signals from proteins
closely associated with the plasma membrane, the ventral membrane
skeleton was exposed by mechanical shear of spreading neutrophils (51,
52). Membrane sheets representing the cytoplasmic faces of basal
membranes contained discrete actin- and supervillin-associated puncta
(Fig. 1B, m-p). These puncta were concentrated
at or near the leading edges of lamellipodial extensions and
occasionally were observed along radially projecting actin bundles.
Staining also appeared as small patches within the interiors of the
adherent membranes. No patches or puncta were observed with nonspecific
rabbit IgG (Fig. 1B, b) or after preadsorption of
the H340 antibody with antigen (Fig. 1B, j),
indicating specificity. These results suggest that supervillin is
associated with a subset of the F-actin-rich neutrophil membrane skeleton that appears as discrete membrane-associated domains.

View larger version (75K):
[in this window]
[in a new window]
|
Fig. 1.
Supervillin and F-actin localizations
in intact neutrophils and membrane sheets. A, specificity of
affinity-purified rabbit polyclonal IgG against supervillin
( H340). Immunoblot of whole bovine neutrophil lysate (100 µg) probed with H340 and HRP-conjugated anti-rabbit secondary
antibody. B, phase (a, e,
i, and m) and immunofluorescence (b-d,
f-h, j-l, and n-p) images of intact
neutrophils (a-h) and the cytoplasmic surfaces of basal
plasma membrane remnants exposed by mechanical shearing of adherent
neutrophils (i-p). Cells and membrane sheets were stained
with rhodamine-phalloidin (F-actin) and Alexa488-labeled
goat F(ab')2 (antibody) against nonspecific
rabbit IgG (control), or affinity-purified H340 IgG
against supervillin ( H340), or H340 IgG that had been
preincubated with 10 µg/ml H340 antigen (pre-adsorbed).
Supervillin localizes within F-actin-rich membrane extensions in
polarized leukocytes (e-h) and as discrete ~200-nm
patches in association with F-actin-rich lamellae in ventral membrane
skeletons exposed by mechanical shear (m-p). Merged images
(d, h, i, and p) show
antibody stain in green, F-actin in red, and
overlap as yellow. Scale bars = 2 µm.
|
|
Supervillin-associated DRMs--
We showed previously that
Triton-insoluble remnants of the neutrophil plasma membrane contained
F-actin and the actin-binding membrane skeleton proteins, fodrin,
myosin-IIA, and supervillin (53). Resistance to solubilization by
Triton X-100 suggested an association with the underlying cytoskeleton
but was also consistent with an association with DRMs. We now report
that, after Triton extraction of neutrophil plasma membranes, these
membrane skeleton proteins exhibit low densities in
OptiprepTM gradients and partition into fractions
containing elevated ratios of cholesterol to protein (Fig.
2, A and B). These
fractions are also enriched in proteins immunoreactive with antibodies
against G i-2 and Lyn kinase (Fig. 2C). All
three of these properties are hallmarks of DRMs (10, 16, 54). The
presence of at least two distinguishable membrane bands at the tops of
the gradients (Fig. 2A, arrows) suggested
heterogeneity, such as that reported for DRMs isolated from lung (55,
56), smooth muscle (57), and tissue culture cells (39, 58).

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 2.
Supervillin co-purifies with cholesterol-rich
DRMs. A, centrifuge tube containing detergent-resistant
plasma membrane (DRM) fragments in buoyant density (d = 1.10-1.18 g/ml) fractions near the top of a 15-50% self-formed
Optiprep gradient. Graphical depiction of this gradient, which contains
membrane fractions 3 and 4, is shown in Fig. 3A.
B, cholesterol/protein ratios in fractions from similar
self-forming Optiprep gradients (bar graph). Values
represent the mean ± S.D. of five independent experiments. The
density profile ( ) of these gradients is sigmoidal, with regions of
low (d < ~1.18 g/ml) and high (d > ~1.20 g/ml) buoyant densities separated by fractions of intermediate
density. Most membrane protein ( ) remains at the bottom of the
gradient (fractions 8-10). C, immunoblots of
samples (50 µg of protein/lane) probed with antibodies against
G i-2, Lyn kinase, or affinity-purified H340 IgG
(supervillin).
|
|
Further purification of this light membrane fraction (Fig.
3A, fraction 4)
from OptiprepTM gradients by sedimentation into linear
20-45% sucrose density gradients demonstrated that neutrophil plasma
membrane DRMs contain both lower buoyant density (DRM-L; Fig.
3A, fraction 5) and higher buoyant density
(DRM-H; Fig. 3A, fraction 6) DRMs. DRM-L
fractions exhibited densities of ~1.09 to 1.13 g/ml, values similar
to those reported for DRMs containing GPI-anchored proteins,
heterotrimeric G-proteins, and Src family kinases (13, 14, 59). DRM-H
fractions exhibited densities of 1.15 to 1.18 g/ml (Fig. 3A)
and were highly enriched in polypeptides with the mobilities of fodrin
and actin (Fig. 3B, arrowheads), membrane
skeleton proteins reported to associate with DRMs (55, 60, 61). These
and other polypeptides were consistently enriched (see below), along
with supervillin (Fig. 3C), during the ~10-20-fold
purification of DRM-H from total Triton-insoluble neutrophil plasma
membranes (Fig. 3B). Conversely, the DRM-H fraction was
depleted of numerous low molecular mass membrane proteins (Fig.
3B, lane 3), as well as of most glycosylated proteins recognized by the lectin, concanavalin A (data not shown).

View larger version (76K):
[in this window]
[in a new window]
|
Fig. 3.
Overview of neutrophil DRM-H isolation.
A, flow chart illustrating the DRM-H isolation procedure, as
detailed under "Experimental Procedures." Fraction numbers
correspond to the lane numbers in B and C. Silver
stain (B) and immunostaining for supervillin (C)
of aliquots (50 µg of protein/lane) of purified neutrophil plasma
membranes (lane 1); Triton-insoluble plasma membrane
fraction (lane 2); dense fraction from Optiprep gradient
(lane 3); light fraction from Optiprep gradient,
i.e. total DRM fraction (lane 4); low buoyant
density (DRM-L) sucrose gradient fraction (lane 5); and high
buoyant density (DRM-H) sucrose gradient fraction (lane 6).
Percentage values of total protein represent the mean ± S.D. from
five independent experiments. Arrowheads denote the
migration positions of fodrin (top) and actin
(bottom). D, thin section (a) and
negatively stained (b and c) electron micrographs
of neutrophil plasma membranes (a) and DRM-H samples at pH
7.4 (b) and pH 5.5 (c). At the low pH conditions
used to spread erythrocyte membrane skeletons (100), we observed 0.1- to 0.5-µm membrane sheets decorated with a semi-regular array of
particles with diameters of ~25 nm or about the diameter of an IgM
pentamer (101). Bars, ~60 nm.
|
|
As visualized by negative stain electron microscopy, the DRM-H fraction
contained both membrane sheets and filamentous material (Fig.
3D). Cytoskeletal filaments reminiscent of those associated with neutrophil plasma membranes (Fig. 3D, a)
also were apparent in micrographs of the DRM-H fraction (Fig. 3D,
b). These filaments were associated with membrane fragments with
surface areas of 0.05-0.5 µm2 that also contained a
semi-regular array of particles with diameters of ~25 nm (Fig.
3D, c). Thus, the DRM-H fraction consisted of detergent-resistant membrane microdomains tightly associated with a
discrete set of membrane skeleton proteins.
Abundant DRM-H Proteins--
We used a mass spectrometric approach
to identify 25 polypeptides in the 23 DRM-H bands that stained most
intensely with Coomassie Blue (Fig. 4).
These polypeptides were representative of 19 proteins or protein
complexes, many of which are characteristic of liquid-ordered microdomains. For instance, the DRM-H proteins, stomatin, flotillin 1, and flotillin 2, are oligomeric integral membrane proteins found in
lipid rafts from erythrocytes, brain, lung, and numerous other tissues
(62-64). The DRM-H fraction also contained the Golgi-associated plant
pathogenesis-related protein-1 (65), the dually acylated non-receptor
tyrosine kinase Lyn, subunits of the heterotrimeric Gi-2
protein, and the GPI-anchored membrane type 6 matrix metalloproteinase (MT-6-MMP, MMP-25, leukolysin). These membrane proteins are targeted to
liquid-ordered microdomains through covalent modifications with
saturated fatty acyl groups (12-14, 17, 59).

View larger version (39K):
[in this window]
[in a new window]
|
Fig. 4.
Identification of the major DRM-H
polypeptides. A, Coomassie Blue-stained polypeptides in the
DRM-H fraction (50 µg), with sizes of molecular mass markers in kDa
on the left and band numbers of excised bands on the
right. B, abbreviations: #, band number;
Mr(kDa), theoretical molecular mass
of major polypeptides based on deduced amino acid sequences;
Identity, based on MALDI-TOF and tandem mass spectrometry
(MS/MS); MALDI-TOF, number of matching fragments/total
fragments; Score, MOWSE score (102); PSD,
peptides confirmed by MS/MS via post source decay; Accession
#, SwissProt/PIR/GenBankTM accession numbers;
WB, Western blot; Raft, lipid-raft associated
protein; Surface, extracellular cell surface-bound protein;
Cytoskeleton, cytoskeletal protein; nd, not
determined. Superscripts: , details in Supplemental
Material; 1, non-erythrocyte spectrin II/ II (fodrin)
dimer/tetramer; 1*, ~150 kDa -fodrin proteolytic
degradation fragment; 2, non-muscle myosin-IIA heavy chain
and regulatory light chain; 3, myosin-IG heavy and
calmodulin regulatory light chain; 4, IgM heavy and light
chain decamer; 5, heterotrimeric Gi-2 protein
and subunits.
|
|
Membrane skeleton proteins constituted a second major category of
proteins in the DRM-H fraction. We found heterodimeric fodrin (nonerythrocyte spectrins II and II), -actin, and other
F-actin binding proteins, including supervillin, -actinin 1, -actinin 4, non-muscle myosin-IIA heavy and light
chains, and the heavy chain and calmodulin light chain of
myosin-IG, an unconventional myosin originally identified as a minor
histocompatibility antigen (66, 67). The DRM-H fraction also contained
the intermediate filament protein, vimentin, which binds fodrin (68)
and which has been reported in other liquid-ordered microdomains (69). The IgM heavy and light chains may be attached extracellularly through
a specific Fc receptor, which is reported to exist on bovine
neutrophils (70-72). Other proteins, such as clathrin, bactenecin (a
positively charged neutrophil defensin), and the G18.1b polypeptide (which is known only as expressed sequence tags and a predicted open
reading frame) are less easily categorized.
To confirm that these proteins were in the same structure as
supervillin, a tightly bound neutrophil membrane skeleton protein (36),
we immunoisolated supervillin-containing lipoprotein complexes from
unfractionated detergent extracts of neutrophil plasma membranes (Fig.
5). Of the many proteins present in the
total Triton X-100 extract of plasma membranes (Fig. 5A,
lane a), a specific subset of at least 15 silver-stained
polypeptides (Fig. 5A, lane d, arrowheads and
dashes) was recovered with beads coated with an affinity-purified IgG
specific for supervillin (Fig. 5A, lane b). These
15 polypeptides were not observed in experiments with nonspecific
rabbit IgG (Fig. 5A, lane c), indicating
specificity. The overall pattern and molecular masses of these
polypeptides (Fig. 5A, arrowheads and
dashes) were very similar to the SDS-gel profile and sizes
of cytoskeletal and signaling proteins identified by mass spectrometric
analysis (Fig. 4A). The identities of eight of these major
silver-stained polypeptides were confirmed by
immunoblotting (Fig. 5B), using antibodies specific for
-fodrin, non-muscle myosin-II, supervillin, Lyn kinase, flotillin 2, -actin, G i-2, and myosin-I head domains. All eight
proteins were specifically adsorbed to Dynabeads coated with
anti-supervillin IgG (Fig. 5B, H340), as
compared with control rabbit IgG (Fig. 5B,
control). The other 10 polypeptides identified in Fig. 4 also may
be present in the anti-supervillin pellets but could not be assayed by
immunoblot analyses due to antibody unavailability, co-migration with
IgG, and/or low molecular mass. Interestingly, similar results were
obtained with both 1% Triton X-100, which does not extract lipid raft
proteins (Fig. 5B, TEB), and with 100 mM octyl glucoside (Fig. 5B, OG),
which does (58, 73). Thus, most or all of the proteins identified as
components of the DRM-H fraction are associated in the same lipoprotein
complexes as supervillin, and these complexes may contain
differentially stabilized lipid raft components.

View larger version (75K):
[in this window]
[in a new window]
|
Fig. 5.
Co-immunopurification of DRM-H proteins with
supervillin. A, silver stain of 100 µg of neutrophil
plasma membranes (lane a); Western blot of same sample
probed with affinity-purified anti-supervillin rabbit IgG (lane
b); silver stain showing proteins co-eluting after preparative
affinity purification with nonspecific (lane c) or
anti-supervillin rabbit IgG (lane d). Positions of
polypeptides confirmed by immunoblotting (arrowheads) and
their numbers designated in Fig. 4 are shown. Lines indicate
the positions of additional bands with molecular masses similar to
those of DRM-H polypeptides identified by mass spectrometry.
Asterisks denote the positions of rabbit IgG heavy and light
chains. B, immunoblots identifying DRM-H proteins that
co-purify with supervillin during adsorption of lipoprotein complexes
to paramagnetic beads coated with nonspecific IgG (control)
or with supervillin-specific H340 antibody ( H340).
These analytical scale adsorptions were performed in the presence of
1% Triton X-100 extraction buffer (TEB) or extraction
buffer with 100 mM octyl glucoside (OG).
Resuspended pellets were loaded for constant volume (80 µl/lane).
|
|
Relative Extractabilities--
To test the relative
strengths of association between DRM-H proteins and lipids, we
extracted the DRM-H fraction with 0.1 M octyl glucoside or
0.1 M sodium carbonate (pH 11.5). Supernatants and
extracted membrane pellets were analyzed for the presence of component
proteins (Fig. 6). We then organized the
resulting immunoblots (Fig. 6, middle columns) from least
extractable, i.e. most tightly bound (Fig. 6,
top), to most extractable, i.e. most weakly bound
(Fig. 6, bottom). Sedimentation of proteins in 1% Triton-extraction buffer (Fig. 6, TEB, left
column) or following membrane solubilization in hot 1% SDS (Fig.
6, SDS, right column) served as negative and
positive controls, respectively. With octyl glucoside (Fig. 6,
OG), we observed partial solubilization of Lyn and IgM, but
relatively little dissociation of the raft proteins, flotillin 2 and
G i-2. In extractions with sodium carbonate (Fig. 6,
Na2CO3), the integral
(flotillin 2) and lipid-anchored (G i-2, Lyn) membrane
proteins were retained in the pellets, as expected. Extractabilities of
the membrane skeleton proteins varied from completely extracted (actin
and -actinin) and ~50% extracted (fodrin) to only ~20-25%
extracted (myosin-IIA and myosin-IG) and virtually unextracted
(supervillin). Because a significant portion of supervillin can be
extracted with 1 M KCl and 0.1 N NaOH (pH 13)
(36), we conclude that it is a peripheral membrane protein that is very
tightly associated with DRM-H lipids and/or integral membrane proteins.
Surprisingly, myosin-IIA and myosin-IG are also relatively tightly
associated with these membranes, remaining bound even after the removal
of all detectable actin.

View larger version (39K):
[in this window]
[in a new window]
|
Fig. 6.
Association of membrane skeleton and
signaling proteins with DRM-H membranes. Purified DRM-H membrane
fragments (Fig. 3, membrane fraction 6) were
extracted with Triton extraction buffer (TEB; negative
control), 100 mM octyl glucoside in extraction buffer
(OG), 0.1 M sodium carbonate (pH 11.5)
(Na2CO3), or 1% hot SDS
(SDS; positive control). Soluble (S) and
insoluble (P) proteins were isolated at 150,000 × g for 60 min. Volumes representing 100 µl of the initial
extraction solutions were separated by SDS-PAGE. Immunoblot strips were
probed using antibody against membrane skeleton and signaling proteins,
as indicated. Most signaling proteins, myosins, and supervillin
remained insoluble, even under conditions (OG) that
solubilize DRM proteins not stabilized by association with cytoskeletal
proteins (73). Actin, -actinin, and most of the fodrin were
extracted by sodium carbonate, which removes loosely bound peripheral
membrane proteins.
|
|
DRM-H Is a Subset of Neutrophil Lipid Domains--
Sucrose density
gradient profiles showed that DRM-H was characterized by increased
amounts of membrane skeleton proteins, whereas most signaling proteins
exhibited a biphasic distribution between DRM-L and DRM-H (Fig.
7, A and B). As
assessed from immunoblot analyses of equal protein loads, all of the
assayed proteins co-isolated to some degree with both DRM-L and DRM-H
(Fig. 7B). The major difference between DRM-L and DRM-H was
the higher percentages of fodrin, supervillin, myosin-IG, and actin
that were associated with DRM-H fractions. DRM-H also contained
significant amounts of myosin-IIA, Lyn kinase, the lipid raft marker
flotillin 2, and G i-2 immunoreactive proteins. Thus,
after Triton extraction of neutrophil plasma membranes, there is both
considerable overlap between the compositions of DRM-L and DRM-H and a
characteristic enrichment of cytoskeletal proteins in association with
DRM-H membranes. Increased association of cytoskeletal proteins
correlates with increased sedimentability in sucrose density gradients
(Fig. 7C).

View larger version (45K):
[in this window]
[in a new window]
|
Fig. 7.
DRM-H represents a membrane
skeleton-associated subset of leukocyte signaling domains.
A, silver-stained fractions (25 µg/lane) after
centrifugation of neutrophil plasma membrane DRMs into a linear
20-45% sucrose density gradient. This gradient contains opalescence
visualized as DRM-L and DRM-H (membrane fractions 5 and
6, in Fig. 3A). Arrows show positions
of the proteins visualized by immunoblot analyses. B,
immunoblot analyses of sucrose density gradient fractions. Fractions
(25 µg/lane) from the gradient shown in A were blotted and
probed with antibody against membrane skeleton (fodrin,
supervillin, myosin-IG, actin, myosin-IIA), coated pit
(clathrin), or lipid raft proteins (Lyn,
flotillin 2, G i-2). Fodrin, supervillin,
myosin-IG, and actin peak together in high buoyant density sucrose
gradient fractions (DRM-H). The heavy chains of myosin-IIA and clathrin
were enriched in fractions of intermediate density. Lyn, flotillin 2, and G i-2 show a biphasic distribution, with a
significant proportion co-purifying with membrane skeleton proteins.
Numbers indicate sucrose density gradient fractions from
top (1) to bottom (16).
Approximate locations are shown for the gradient load (L),
low density DRMs (DRM-L), coated pits (CP), high
density DRMs (DRM-H), and pellet (P).
C, densities ( ) and apparent protein concentrations ( )
of the sucrose gradient fractions shown in A. D,
confocal immunofluorescence images show partial co-localization of
supervillin and G i in peripheral micropatches of
unroofed neutrophils. Neutrophils spread on
poly-L-lysine-coated coverslips were mechanically sheared
and stained with Alexa488- and Alexa568-labeled goat secondary
antibodies against rabbit polyclonal anti-supervillin IgG and mouse
monoclonal anti-G i-2 IgG, respectively. Partial overlap
(yellow) of the supervillin (green) and
G i (red) signals is apparent in the merged
image. Scale bar = 2 µm.
|
|
In agreement with the observation of overlapping and distinct
biochemical pools of supervillin and G i proteins (Fig.
7B), we observed partial but significant overlap between the
supervillin and G i immunofluorescent signals in adherent
membrane fragments from lysed neutrophils (Fig. 7D). This
co-localization was especially prominent in puncta at the
F-actin-rich membrane peripheries of actively spreading cells (Fig.
7D, a-c). By contrast, only occasional overlap
of supervillin and G i signals was observed in the
centers of the membrane remnants (Fig. 7D, d-f).
The extent of co-localization observed by immunofluorescence microscopy
(Fig. 7D) was roughly consistent with the degree to which
supervillin and G i-2 immunoreactive proteins co-purified
in the DRM-H sucrose density fractions (Fig. 7B). Taken
together with the identification of G i-2 as a major co-purifying protein (Fig. 4), these observations suggest that supervillin both co-localizes and co-purifies with a subset of G i-2-associated signaling domains. These results further
suggest that the isolated DRM-L and DRM-H fractions represent different lateral domains within the neutrophil plasma membrane.
 |
DISCUSSION |
In this paper, we present proteomic and microscopic evidence for a
DRM-associated membrane skeleton from neutrophil plasma membranes
(Figs. 1-7). This lipoprotein complex is enriched in cholesterol (Fig.
2) and exhibits a higher buoyant density than do DRMs with less
associated membrane skeleton material (Figs. 3 and 7, DRM-H versus DRM-L). Cytoskeletal proteins characteristically
enriched in this fraction include fodrin, supervillin, myosin-IIA,
myosin-IG, and -actinins 1 and 4 (Figs. 3-7). Immunoaffinity
purification of supervillin-associated DRM complexes confirms that
these proteins are in the same lipoprotein complexes (Fig. 5). Octyl
glucoside extraction demonstrates that most of the hydrophobically
associated lipid raft proteins in this complex are relatively
stabilized against extraction by this detergent (Figs. 5 and 6).
Carbonate extraction demonstrates that the peripheral membrane
proteins, supervillin, myosin-IIA, and myosin-IG, are very tightly
associated with DRM lipids and/or integral membrane proteins, remaining
bound even in the absence of detectable actin (Fig. 6). As supervillin and G i-2 immunoreactive proteins appear to
preferentially co-localize in actin-rich areas of cells engaged in
active spreading (Figs. 1 and 7D), the DRM-H fraction may
represent a transiently induced, membrane skeleton-associated subset of
neutrophil signaling domains (Fig.
8).

View larger version (34K):
[in this window]
[in a new window]
|
Fig. 8.
Working model of the DRM-H membrane
skeleton. Hypothetical organization of the DRM-H membrane skeleton
in neutrophil plasma membranes based on proteomic and microscopic
evidence presented in this paper. DRM-H lipoprotein complexes are
enriched in cholesterol and contain the integral membrane
raft-associated proteins: stomatin, flotillin 1, and flotillin 2. These
oligomeric proteins and tightly bound lipids are depicted here as a
"lipid raft." Additional proteins typically associated
with liquid-ordered domains are also present, including an
extracellular GPI-anchored protein (MT6-MMP), and
intracellular dually acylated signaling proteins (Lyn,
G i-2). Extracellular surface-bound IgM may be
attached through a specific receptor. DRM-H rafts are characterized by
a relatively high buoyant density in sucrose, due to their association
with membrane skeleton proteins (fodrin, F-actin,
-actinin, vimentin, myosin-IIA,
myosin-IG, and supervillin). DRM-bound
supervillin, myosin-IG, and myosin-IIA resist extraction with 0.1 M sodium carbonate, a treatment that removes all detectable
actin and -actinin, suggesting that the unextracted cytoskeletal
proteins are more proximal to the DRM-H bilayer.
|
|
The buoyant density of the DRM-H fraction (d ~1.16 g/ml)
is probably the reason it has not been described previously. DRM purification methods typically involve the collection of lipoprotein complexes with densities within the range of 1.02 to 1.16 (5-35% sucrose) (39, 74), whereas Triton-insoluble membrane skeletons characteristically exhibit densities of 1.25-1.3 (~50-64% sucrose) (75, 76). Presumably, attachment of DRM-associated proteins to the
cytoskeleton causes an increased density due to the increased ratio of
protein to lipid in the detergent-resistant fraction, resulting in equilibrium banding at intermediate sucrose
concentrations. DRMs with densities in the range of our DRM-H fraction
(d ~ 1.15-1.18; 33-40% sucrose) are likely to
sediment, or to be spread throughout, the 30-35% sucrose step
gradient used in many DRM purification methods (39, 74). Similarly, the
DRM-H fraction would not be detected in related lipoprotein complexes
prepared in the absence of nonionic detergents (58, 77, 78) because
these complexes are isolated after carbonate extraction and/or
sonication, procedures that remove most associated cytoskeletal
proteins (e.g. Fig. 6).
Although DRMs are commonly assumed to reflect the compositions and
morphologies of lipid domains in vivo, these isolated
structures may differ in detail from their endogenous counterparts (54, 58, 79). Also, the isolated DRM-H fraction is not necessarily homogeneous with respect to the relative ratios of the co-isolating proteins. For instance, the small amount of DRM-H clathrin (Fig. 4) may
be caused by a few contaminating coated pits or it may represent a
limited association between coated membrane and a subset of DRMs. Other
components of the DRM-H fraction, especially proteins present in minor
amounts, remain for future analysis. The determination of which
proteins interact through direct interactions and which are
co-associated through a common affinity for the gel-phase DRM lipids is
similarly beyond the scope of this investigation. However, the
silver-stained profile of proteins that co-sediment as the DRM-H
fraction (Figs. 3, 4, and 7) is similar to the pattern of proteins that
are co-purified using antibodies directed against supervillin (Fig. 5).
This result suggests that supervillin directly or indirectly associates
with lipoprotein complexes containing the other proteins in Fig. 4 and
may therefore serve as a marker protein for DRM-H rafts in neutrophil
plasma membranes.
Our results are consistent with electron microscopic observations of a
subplasmalemmal filament complex associated with Triton X-100-extracted
neutrophil ghosts (80) and plasma membrane remnants of sheared
neutrophils (51, 52). In the latter studies, high resolution scanning electron micrographs revealed that the cytoplasmic surfaces of adherent, spreading neutrophils contain interlocking networks of globular centers and radiating branched filaments. Morphologically similar networks are observed in cross-sections of
purified plasma membranes (Fig. 3D, a) and in
negatively stained DRM-H samples (Fig. 3D, b and
c). Given our observations of myosin-IIA and myosin-IG bound
to DRMs lacking detectable F-actin, these domains may represent
regions where actin and myosin are recruited and organized at the
membrane, as originally implied (52).
Our data also agree with the initial observation that neutrophils
contain a fodrin- and actin-based, detergent-resistant membrane skeleton (35). This membrane skeleton has been implicated in the
lateral organization of components of the superoxide-generating machinery (81) and in the segregation of chemoreceptors and Gi-2 proteins during neutrophil stimulation (34, 82-85).
The partial superimposition of the supervillin and G i-2
immunofluorescence signals (Fig. 7D) suggests that at least
some of these areas of overlap may correspond to domains involved in
the active signaling between chemotactic receptors and the actin cytoskeleton.
Actin, spectrin, or fodrin, and/or associated proteins have been
co-purified with lipid raft components from other hematopoietic cell
types. For example, erythrocyte DRMs are enriched in stomatin, flotillins 1 and 2, -actin, and a loosely bound member of the spectrin gene family (65). More recently, a complex mixture of DRMs
from unstimulated Jurkat T lymphocytes was found to contain a subset of
proteins reminiscent of those identified here (39). Among a total of
~70 DRM proteins, including markers for mitochondria, rough
endoplasmic reticulum, the Golgi complex, and the nuclear envelope,
were sequences representative of fodrin, myosin-IIA heavy and light
chains, supervillin, myosin-IG (GenBankTM accession number
AI089291), vimentin, -actin, flotillin 2, G i-2, and
the Src-related tyrosine kinase Lck. Although it is not known whether
these proteins co-associate with each other in T cells, as opposed to
being present in different DRMs, it is striking that 12 of the 25 polypeptides identified in our study are also present in total Jurkat T
cell DRMs. Thus, lipid raft-associated membrane skeletons similar to
DRM-H may be present in hematopoietic cells of different origin.
The neutrophil DRM-H fraction also exhibits some compositional
similarities to the microdomains associated with the multichain receptor for IgE (Fc R) in mast cells (86, 87). Both types of domains
are cholesterol-rich and contain bound immunoglobulin, actin, and Lyn
kinase (19, 88). The relatively tight association of IgM with DRM-H
fragments (Fig. 6) is consistent with the reported presence of a
specific receptor for IgM on bovine neutrophils (70-72). In mouse and
human, an ~70-kDa receptor that binds IgA as well as IgM (Fc /µR)
has been shown to mediate internalization of IgM-coated
Staphylococcus aureus (89). Another Fcµ receptor exists as
an ~60-kDa GPI-linked isoform in hematopoietic cells (90, 91). Either
type of Fcµ receptor would be hard to detect in the presence of the
more abundant, co-electrophoresing IgM decamer, leaving open the
question of whether the IgM that co-sediments with the neutrophil DRM-H
fraction is bound through a specific Fc receptor.
Although not documented previously, the actin-independent association
of myosins and other F-actin-binding proteins with DRMs is consistent
with reports (92, 93) indicating that lipid raft domains are
intrinsically linked to active movements of the cortical actin
cytoskeleton. After priming by receptor occupancy with IgE, for
example, the Fc R is associated with Lyn in lipid rafts on mast cells
(86). Following receptor cross-linking by multivalent antigen, the
structure and organization of these microdomains are changed both by
actin-based lateral movements of signal transduction proteins within
the plane of the membrane and by recruitment of signaling proteins from
cytoplasmic stores (94, 95). Similar mechanisms also target specific
lipid raft components to the front and rear of polarized leukocytes
(24, 25, 96) and to the immunological synapses of stimulated T cells
(93, 97).
We hypothesize that fodrin, myosin-IIA, myosin-IG, and supervillin are
components of a mobile, actin-based membrane skeleton that regulates
the organization and/or transport of cholesterol-rich signaling domains
at the neutrophil plasma membrane (Fig. 8). Associations with membrane
skeleton components also could differentially stabilize and/or localize
these domains within the membrane. Whereas the intracellular
localization of myosin-IG is unknown, fodrin and myosin-II both
localize throughout the cortex, as well as at the plasma membrane (98,
99). By contrast, plasma membrane-associated supervillin is observed as
puncta or patches in many cell types (36, 38), suggesting that
supervillin may be a characteristic component of this type of lipid
raft-associated membrane skeleton. The tight association between
supervillin and DRM-H fragments, in conjunction with the high affinity
binding of supervillin for F-actin and its ability to reorganize
cytoskeletal structures (36, 38), suggests that supervillin may be
involved in recruitment of the actin-based cytoskeleton to such
liquid-ordered regions of the plasma membrane. The tight association of
myosin motors with the DRM-H fragments suggests the possibility of a
role in membrane transport or directed motility at the cell surface.
 |
ACKNOWLEDGEMENTS |
We gratefully acknowledge Dr. Gregory
Hendricks for assistance with the electron microscopy, Drs.
Mark Mooseker and Martin Bähler for their generous gifts of
antibodies against myosin I sequences, and Dr. Silvia Corvera for
providing anti-clathrin heavy chain antibody. We also thank Megan
Staples for help with immunoaffinity purification, Louise Ohrn for the
megaliters of solutions used for plasma membrane purification, and
Ernestina Bernal and Donna Castellanos for expert glassware washing.
 |
FOOTNOTES |
*
This work was supported by Grant GM33048 from the National
Institutes of Health.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The on-line version of this article (available at
http://www.jbc.org) contains information for Fig. 4.
§
Present address: Scripps Research Institute, 10550 N. Torrey Pines
Rd., La Jolla, CA 92037.
To whom correspondence should be addressed: Dept. of Cell
Biology, University of Massachusetts Medical School, Biotech 4, Ste.
306, 377 Plantation St., Worcester, MA 01605. Tel.: 508-856-8661; Fax:
508-856-8774; E-mail: Elizabeth.Luna@umassmed.edu.
Published, JBC Papers in Press, August 28, 2002, DOI 10.1074/jbc.M205386200
 |
ABBREVIATIONS |
The abbreviations used are:
DRM, detergent-resistant membrane fragments;
DRM-H, DRMs with higher buoyant
densities (1.15-1.18 g/ml);
DRM-L, DRMs with lower buoyant densities
(1.09-1.13 g/ml);
H340, antibodies against the amino-terminal 340 amino acids of human supervillin;
GPI, glycophosphatidylinositol;
GST, glutathione S-transferase;
H340, the amino-terminal 340 amino acids of human supervillin;
HRP, horseradish peroxidase;
MALDI-TOF, matrix-assisted laser desorption/ionization time of flight;
MS/MS, tandem mass spectrometry;
MT-6-MMP, membrane-type 6 matrix
metalloproteinase;
PSD, post-source-decay;
PIPES, 1,4-piperazinediethanesulfonic acid.
 |
REFERENCES |
| 1.
|
Jonkman, M. F.
(1999)
J. Dermatol. Sci.
20,
103-121[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
McMillan, J. R.,
and Shimizu, H.
(2001)
J. Dermatol. (Tokyo)
28,
291-298
|
| 3.
|
Bennett, V.,
and Baines, A. J.
(2001)
Physiol. Rev.
81,
1353-1392[Abstract/Free Full Text]
|
| 4.
|
Bloch, R. J.,
Bezakova, G.,
Ursitti, J. A.,
Zhou, D.,
and Pumplin, D. W.
(1997)
Soc. Gen. Physiol. Ser.
52,
177-195[Medline]
[Order article via Infotrieve]
|
| 5.
|
Geiger, B.,
and Bershadsky, A.
(2001)
Curr. Opin. Cell Biol.
13,
584-592[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Lange, K.
(2002)
Am. J. Physiol.
282,
C1-C26
|
| 7.
|
Nagafuchi, A.
(2001)
Curr. Opin. Cell Biol.
13,
600-603[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Luna, E. J.,
and Hitt, A. L.
(1992)
Science
258,
955-964[Abstract/Free Full Text]
|
| 9.
|
London, E.,
and Brown, D. A.
(2000)
Biochim. Biophys. Acta
1508,
182-195[Medline]
[Order article via Infotrieve]
|
| 10.
|
Rietveld, A.,
and Simons, K.
(1998)
Biochim. Biophys. Acta
1376,
467-479[Medline]
[Order article via Infotrieve]
|
| 11.
|
Galbiati, F.,
Razani, B.,
and Lisanti, M. P.
(2001)
Cell
106,
403-411[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Benting, J.,
Rietveld, A.,
Ansorge, I.,
and Simons, K.
(1999)
FEBS Lett.
462,
47-50[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Melkonian, K. A.,
Ostermeyer, A. G.,
Chen, J. Z.,
Roth, M. G.,
and Brown, D. A.
(1999)
J. Biol. Chem.
274,
3910-3917[Abstract/Free Full Text]
|
| 14.
|
Moffett, S.,
Brown, D. A.,
and Linder, M. E.
(2000)
J. Biol. Chem.
275,
2191-2198[Abstract/Free Full Text]
|
| 15.
|
Zacharias, D. A.,
Violin, J. D.,
Newton, A. C.,
and Tsien, R. Y.
(2002)
Science
296,
913-916[Abstract/Free Full Text]
|
| 16.
|
Pralle, A.,
Keller, P.,
Florin, E. L.,
Simons, K.,
and Horber, J. K.
(2000)
J. Cell Biol.
148,
997-1008[Abstract/Free Full Text]
|
| 17.
|
Varma, R.,
and Mayor, S.
(1998)
Nature
394,
798-801[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Friedrichson, T.,
and Kurzchalia, T. V.
(1998)
Nature
394,
802-805[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Simons, K.,
and Toomre, D.
(2000)
Nat. Rev. Mol. Cell. Biol.
1,
31-39[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Thomas, J. L.,
Holowka, D.,
Baird, B.,
and Webb, W. W.
(1994)
J. Cell Biol.
125,
795-802[Abstract/Free Full Text]
|
| 21.
|
Pike, L. J.,
Han, X.,
Chung, K. N.,
and Gross, R. W.
(2002)
Biochemistry
41,
2075-2088[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Bickel, P. E.
(2002)
Am. J. Physiol.
282,
E1-E10
|
| 23.
|
Mukherjee, S.,
and Maxfield, F. R.
(2000)
Traffic
1,
203-211[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Gomez-Mouton, C.,
Abad, J. L.,
Mira, E.,
Lacalle, R. A.,
Gallardo, E.,
Jimenez-Baranda, S.,
Illa, I.,
Bernad, A.,
Manes, S.,
and Martinez, A. C.
(2001)
Proc. Natl. Acad. Sci. U. S. A.
98,
9642-9647[Abstract/Free Full Text]
|
| 25.
|
Seveau, S.,
Eddy, R. J.,
Maxfield, F. R.,
and Pierini, L. M.
(2001)
Mol. Biol. Cell
12,
3550-3562[Abstract/Free Full Text]
|
| 26.
|
Stossel, T. P.
(1994)
Sci. Am.
271,
54-55[Medline]
[Order article via Infotrieve], 58-63
|
| 27.
|
Mottola, C.,
Gennaro, R.,
Marzullo, A.,
and Romeo, D.
(1980)
Eur. J. Biochem.
111,
341-346[Medline]
[Order article via Infotrieve]
|
| 28.
|
Pestonjamasp, K.,
Amieva, M. R.,
Strassel, C. P.,
Nauseef, W. M.,
Furthmayr, H.,
and Luna, E. J.
(1995)
Mol. Biol. Cell
6,
247-259[Abstract]
|
| 29.
|
Salgar, S. K.,
Paape, M. J.,
and Alston-Mills, B.
(1994)
Am. J. Vet. Res.
55,
803-809[Medline]
[Order article via Infotrieve]
|
| 30.
|
Stossel, T. P.,
and Babior, B. M.
(1995)
in
Blood: Principles and Practice of Hematology
(Handin, R. I.
, Stossel, T. P.
, and Lux, S. E., eds)
, pp. 575-619, J. B. Lippincott, Philadelphia
|
| 31.
|
Godaly, G.,
Bergsten, G.,
Hang, L.,
Fischer, H.,
Frendeus, B.,
Lundstedt, A. C.,
Samuelsson, M.,
Samuelsson, P.,
and Svanborg, C.
(2001)
J. Leukocyte Biol.
69,
899-906[Abstract/Free Full Text]
|
| 32.
|
Nabi, I. R.
(1999)
J. Cell Sci.
112,
1803-1811[Abstract]
|
| 33.
|
Jones, G. E.
(2000)
J. Leukocyte Biol.
68,
593-602[Abstract/Free Full Text]
|
| 34.
|
Jesaitis, A. J.,
Bokoch, G. M.,
Tolley, J. O.,
and Allen, R. A.
(1988)
J. Cell Biol.
107,
921-928[Abstract/Free Full Text]
|
| 35.
|
Stevenson, K. B.,
Clark, R. A.,
and Nauseef, W. M.
(1989)
Blood
74,
2136-2143[Abstract/Free Full Text]
|
| 36.
|
Pestonjamasp, K. N.,
Pope, R. K.,
Wulfkuhle, J. D.,
and Luna, E. J.
(1997)
J. Cell Biol.
139,
1255-1269[Abstract/Free Full Text]
|
| 37.
|
Pope, R. K.,
Pestonjamasp, K. N.,
Smith, K. P.,
Wulfkuhle, J. D.,
Strassel, C. P.,
Lawrence, J. B.,
and Luna, E. J.
(1998)
Genomics
52,
342-351[CrossRef][Medline]
[Order article via Infotrieve]
|
| 38.
|
Wulfkuhle, J. D.,
Donina, I. E.,
Stark, N. H.,
Pope, R. K.,
Pestonjamasp, K. N.,
Niswonger, M. L.,
and Luna, E. J.
(1999)
J. Cell Sci.
112,
2125-2136[Abstract]
|
| 39.
|
von Haller, P. D.,
Donohoe, S.,
Goodlett, D. R.,
Aebersold, R.,
and Watts, J. D.
(2001)
Proteomics
1,
1010-1021[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Kim, M.,
Jiang, L. H.,
Wilson, H. L.,
North, R. A.,
and Surprenant, A.
(2001)
EMBO J.
20,
6347-6358[CrossRef][Medline]
[Order article via Infotrieve]
|
| 41.
|
Morozumi, T.,
Kubota, T.,
Sugita, N.,
Ohsawa, Y.,
Yamazaki, K.,
and Yoshie, H.
(2001)
J. Periodontal Res.
36,
160-168[CrossRef][Medline]
[Order article via Infotrieve]
|
| 42.
|
Carboni, J. M.,
Howe, C. L.,
West, A. B.,
Barwick, K. W.,
Mooseker, M. S.,
and Morrow, J. S.
(1987)
Am. J. Pathol.
129,
589-600[Abstract]
|
| 43.
|
Peterson, M. D.,
and Mooseker, M. S.
(1992)
J. Cell Sci.
102,
581-600[Abstract/Free Full Text]
|
| 44.
|
Ruppert, C.,
Godel, J.,
Muller, R. T.,
Kroschewski, R.,
Reinhard, J.,
and Bähler, M.
(1995)
J. Cell Sci.
108,
3775-3786[Abstract]
|
| 45.
|
Del Buono, B. J.,
Luscinskas, F. W.,
and Simons, E. R.
(1989)
J. Cell. Physiol.
141,
636-644[CrossRef][Medline]
[Order article via Infotrieve]
|
| 46.
|
Hartwig, J. H.,
Chambers, K. A.,
and Stossel, T. P.
(1989)
J. Cell Biol.
108,
467-479[Abstract/Free Full Text]
|
| 47.
|
Bremer, A.,
Häner, M.,
and Aebi, U.
(1998)
in
Cell Biology: A Laboratory Handbook
(Celis, J., ed), 2nd Ed., Vol. 3
, pp. 277-284, Academic Press, Boston
|
| 48.
|
Laemmli, U. K.
(1970)
Nature
227,
680-685[CrossRef][Medline]
[Order article via Infotrieve]
|
| 49.
|
Dell'Angelica, E.,
and Bonifacino, J.
(2000)
in
Current Protocols in Cell Biology
(Bonifacino, J.
, Dasso, M.
, Harford, J.
, Lippincott-Schwartz, J.
, and Yamada, K., eds), Vol. 1
, pp. 6.6.1-6.6.2, John Wiley & Sons, Inc., New York
|
| 50.
|
Gharahdaghi, F.,
Weinberg, C. R.,
Meagher, D. A.,
Imai, B. S.,
and Mische, S. M.
(1999)
Electrophoresis
20,
601-605[CrossRef][Medline]
[Order article via Infotrieve]
|
| 51.
|
Boyles, J.,
and Bainton, D. F.
(1979)
J. Cell Biol.
82,
347-368[Abstract/Free Full Text]
|
| 52.
|
Boyles, J.,
and Bainton, D. F.
(1981)
Cell
24,
905-914[CrossRef][Medline]
[Order article via Infotrieve]
|
| 53.
|
Luna, E. J.,
Pestonjamasp, K. N.,
Cheney, R. E.,
Strassel, C. P., Lu, T. H.,
Chia, C. P.,
Hitt, A. L.,
Fechheimer, M.,
Furthmayr, H.,
and Mooseker, M. S.
(1997)
Soc. Gen. Physiol. Ser.
52,
3-18[Medline]
[Order article via Infotrieve]
|
| 54.
|
Brown, D. A.,
and London, E.
(1998)
Annu. Rev. Cell Dev. Biol.
14,
111-136[CrossRef][Medline]
[Order article via Infotrieve]
|
| 55.
|
Lisanti, M. P.,
Scherer, P. E.,
Vidugiriene, J.,
Tang, Z.,
Hermanowski-Vosatka, A., Tu, Y.-H.,
Cook, R. F.,
and Sargiacomo, M.
(1994)
J. Cell Biol.
126,
111-126[Abstract/Free Full Text]
|
| 56.
|
Schnitzer, J. E.,
McIntosh, D. P.,
Dvorak, A. M.,
Liu, J.,
and Oh, P.
(1995)
Science
269,
1435-1439[Abstract/Free Full Text]
|
| 57.
|
Chang, W.-J.,
Ying, Y.,
Rothberg, K. G.,
Hooper, N. M.,
Turner, A. J.,
Gambliel, H. A., De,
Gunzburg, J.,
Mumby, S. M.,
Gilman, A. G.,
and Anderson, R. G. W.
(1994)
J. Cell Biol.
126,
127-138[Abstract/Free Full Text]
|
| 58.
|
Smart, E. J.,
Ying, Y.-S.,
Mineo, C.,
and Anderson, R. G. W.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
10104-10108[Abstract/Free Full Text]
|
| 59.
|
Oh, P.,
and Schnitzer, J. E.
(2001)
Mol. Biol. Cell
12,
685-698[Abstract/Free Full Text]
|
| 60.
|
Nelson, W. J.,
and Hammerton, R. W.
(1989)
J. Cell Biol.
108,
893-902[Abstract/Free Full Text]
|
| 61.
|
Fujimoto, T.,
Nakade, S.,
Miyawaki, A.,
Mikoshiba, K.,
and Ogawa, K.
(1992)
J. Cell Biol.
119,
1507-1513[Abstract/Free Full Text]
|
| 62.
|
Bickel, P. E.,
Scherer, P. E.,
Schnitzer, J. E., Oh, P.,
Lisanti, M. P.,
and Lodish, H. F.
(1997)
J. Biol. Chem.
272,
13793-13802[Abstract/Free Full Text]
|
| 63.
|
Eberle, H. B.,
Serrano, R. L.,
Fullekrug, J.,
Schlosser, A.,
Lehmann, W. D.,
Lottspeich, F.,
Kaloyanova, D.,
Wieland, F. T.,
and Helms, J. B.
(2002)
J. Cell Sci.
115,
827-838[Abstract/Free Full Text]
|
| 64.
|
Schulte, T.,
Paschke, K. A.,
Laessing, U.,
Lottspeich, F.,
and Stuermer, C. A.
(1997)
Development
124,
577-587[Abstract]
|
| 65.
|
Salzer, U.,
and Prohaska, R.
(2001)
Blood
97,
1141-1143[Abstract/Free Full Text]
|
| 66.
|
den Haan, J. M.,
Sherman, N. E.,
Blokland, E.,
Huczko, E.,
Koning, F.,
Drijfhout, J. W.,
Skipper, J.,
Shabanowitz, J.,
Hunt, D. F.,
Engelhard, V. H.,
and Goulmy, E.
(1995)
Science
268,
1476-1480[Abstract/Free Full Text]
|
| 67.
|
Pierce, R. A.,
Field, E. D.,
Mutis, T.,
Golovina, T. N.,
Von Kap-Herr, C.,
Wilke, M.,
Pool, J.,
Shabanowitz, J.,
Pettenati, M. J.,
Eisenlohr, L. C.,
Hunt, D. F.,
Goulmy, E.,
and Engelhard, V. H.
(2001)
J. Immunol.
167,
3223-3230[Abstract/Free Full Text]
|
| 68.
|
Langley, R. C., Jr.,
and Cohen, C. M.
(1987)
Cell Motil. Cytoskeleton
8,
165-173[CrossRef][Medline]
[Order article via Infotrieve]
|
| 69.
|
Runembert, I.,
Queffeulou, G.,
Federici, P.,
Vrtovsnik, F.,
Colucci-Guyon, E.,
Babinet, C.,
Briand, P.,
Trugnan, G.,
Friedlander, G.,
and Terzi, F.
(2002)
J. Cell Sci.
115,
713-724[Abstract/Free Full Text]
|
| 70.
|
Grewal, A. S.,
Rouse, B. T.,
and Babiuk, L. A.
(1978)
Int. Arch. Allergy Appl. Immunol.
56,
289-300[Medline]
[Order article via Infotrieve]
|
| 71.
|
Williams, M. R.,
and Hill, A. W.
(1982)
Res. Vet. Sci.
33,
47-53[Medline]
[Order article via Infotrieve]
|
| 72.
|
Worku, M.,
Paape, M. J.,
Filep, R.,
and Miller, R. H.
(1994)
Am. J. Vet. Res.
55,
221-226[Medline]
[Order article via Infotrieve]
|
| 73.
|
Melkonian, K. A.,
Chu, T.,
Tortorella, L. B.,
and Brown, D. A.
(1995)
Biochemistry
34,
16161-16170[CrossRef][Medline]
[Order article via Infotrieve]
|
| 74.
|
Fiedler, K.,
Kobayashi, T.,
Kurzchalia, T. V.,
and Simons, K.
(1993)
Biochemistry
32,
6365-6373[CrossRef][Medline]
[Order article via Infotrieve]
|
| 75.
|
Goodloe-Holland, C. M.,
and Luna, E. J.
(1987)
Methods Cell Biol.
28,
103-128[Medline]
[Order article via Infotrieve]
|
| 76.
|
Sheetz, M. P.
(1979)
Biochim. Biophys. Acta
557,
122-134[Medline]
[Order article via Infotrieve]
|
| 77.
|
Song, K. S., Li, S.,
Okamoto, T.,
Quilliam, L. A.,
Sargiacomo, M.,
and Lisanti, M. P.
(1996)
J. Biol. Chem.
271,
9690-9697[Abstract/Free Full Text]
|
| 78.
|
Waugh, M. G.,
Lawson, D.,
and Hsuan, J. J.
(1999)
Biochem. J.
337,
591-597[CrossRef][Medline]
[Order article via Infotrieve]
|
| 79.
|
Dobrowsky, R. T.
(2000)
Cell. Signal.
12,
81-90[CrossRef][Medline]
[Order article via Infotrieve]
|
| 80.
|
Jesaitis, A. J.,
Naemura, J. R.,
Sklar, L. A.,
Cochrane, C. G.,
and Painter, R. G.
(1984)
J. Cell Biol.
98,
1378-1387[Abstract/Free Full Text]
|
| 81.
|
Quinn, M. T.,
Parkos, C. A.,
and Jesaitis, A. J.
(1989)
Biochim. Biophys. Acta
987,
83-94[Medline]
[Order article via Infotrieve]
|
| 82.
|
Jesaitis, A. J.,
Tolley, J. O.,
Bokoch, G. M.,
and Allen, R. A.
(1989)
J. Cell Biol.
109,
2783-2790[Abstract/Free Full Text]
|
| 83.
|
Klotz, K.-N.,
and Jesaitis, A. J.
(1994)
Bioessays
16,
193-198[CrossRef][Medline]
[Order article via Infotrieve]
|
| 84.
|
Sarndahl, E.,
Bokoch, G. M.,
Boulay, F.,
Stendahl, O.,
and Andersson, T.
(1996)
J. Biol. Chem.
271,
15267-15271[Abstract/Free Full Text]
|
| 85.
|
Sengelov, H.,
Boulay, F.,
Kjeldsen, L.,
and Borregaard, N.
(1994)
Biochem. J.
299,
473-479[Medline]
[Order article via Infotrieve]
|
| 86.
|
Field, K. A.,
Holowka, D.,
and Baird, B.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
9201-9205[Abstract/Free Full Text]
|
| 87.
|
Holowka, D.,
and Baird, B.
(2001)
Semin. Immunol.
13,
99-105[CrossRef][Medline]
[Order article via Infotrieve]
|
| 88.
|
Dykstra, M.,
Cherukuri, A.,
and Pierce, S. K.
(2001)
J. Leukocyte Biol.
70,
699-707[Abstract/Free Full Text]
|
| 89.
|
Shibuya, A.,
Sakamoto, N.,
Shimizu, Y.,
Shibuya, K.,
Osawa, M.,
Hiroyama, T.,
Eyre, H. J.,
Sutherland, G. R.,
Endo, Y.,
Fujita, T.,
Miyabayashi, T.,
Sakano, S.,
Tsuji, T.,
Nakayama, E.,
Phillips, J. H.,
Lanier, L. L.,
and Nakauchi, H.
(2000)
Nat. Immunol.
1,
441-446[CrossRef][Medline]
[Order article via Infotrieve]
|
| 90.
|
Nakamura, T.,
Kubagawa, H.,
Ohno, T.,
and Cooper, M. D.
(1993)
J. Immunol.
151,
6933-6941[Abstract]
|
| 91.
|
Ohno, T.,
Kubagawa, H.,
Sanders, S. K.,
and Cooper, M. D.
(1990)
J. Exp. Med.
172,
1165-1175[Abstract/Free Full Text]
|
| 92.
|
Rodgers, W.,
and Zavzavadjian, J.
(2001)
Exp. Cell Res.
267,
173-183[CrossRef][Medline]
[Order article via Infotrieve]
|
| 93.
|
Valensin, S.,
Paccani, S. R.,
Ulivieri, C.,
Mercati, D.,
Pacini, S.,
Patrussi, L.,
Hirst, T.,
Lupetti, P.,
and Baldari, C. T.
(2002)
Eur. J. Immunol.
32,
435-446[CrossRef][Medline]
[Order article via Infotrieve]
|
| 94.
|
Wilson, B. S.,
Pfeiffer, J. R.,
and Oliver, J. M.
(2000)
J. Cell Biol.
149,
1131-1142[Abstract/Free Full Text]
|
| 95.
|
Holowka, D.,
Sheets, E. D.,
and Baird, B.
(2000)
J. Cell Sci.
113,
1009-1019[Abstract]
|
| 96.
|
Manes, S.,
Mira, E.,
Gomez-Mouton, C.,
Lacalle, R. A.,
Keller, P.,
Labrador, J. P.,
and Martinez, A. C.
(1999)
EMBO J.
18,
6211-6220[CrossRef][Medline]
[Order article via Infotrieve]
|
| 97.
|
Villalba, M., Bi, K.,
Rodriguez, F.,
Tanaka, Y.,
Schoenberger, S.,
and Altman, A.
(2001)
J. Cell Biol.
155,
331-338[Abstract/Free Full Text]
|
| 98.
|
Fujimoto, T.,
and Ogawa, K.
(1990)
J. Cell Sci.
96,
477-484[Abstract/Free Full Text]
|
| 99.
|
Valerius, N. H.,
Stendahl, O.,
Hartwig, J. H.,
and Stossel, T. P.
(1981)
Cell
24,
195-202[CrossRef][Medline]
[Order article via Infotrieve]
|
| 100.
|
Byers, T. J.,
and Branton, D.
(1985)
Proc. Natl. Acad. Sci. U. S. A.
82,
6153-6157[Abstract/Free Full Text]
|
| 101.
|
Feinstein, A.,
and Munn, E. A.
(1969)
Nature
224,
1307-1309[CrossRef][Medline]
[Order article via Infotrieve]
|
| 102.
|
Pappin, D. J.
(1997)
Methods Mol. Biol.
64,
165-173[Medline]
[Order article via Infotrieve]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Y. Z. Zheng, K. B. Berg, and L. J. Foster
Mitochondria do not contain lipid rafts, and lipid rafts do not contain mitochondrial proteins
J. Lipid Res.,
May 1, 2009;
50(5):
988 - 998.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Marois, M. Vaillancourt, S. Marois, S. Proulx, G. Pare, E. Rollet-Labelle, and P. H. Naccache
The Ubiquitin Ligase c-Cbl Down-Regulates Fc{gamma}RIIa Activation in Human Neutrophils
J. Immunol.,
February 15, 2009;
182(4):
2374 - 2384.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Minami, M. Fujiwara, A. Furuto, Y. Fukao, T. Yamashita, M. Kamo, Y. Kawamura, and M. Uemura
Alterations in Detergent-Resistant Plasma Membrane Microdomains in Arabidopsis thaliana During Cold Acclimation
Plant Cell Physiol.,
February 1, 2009;
50(2):
341 - 359.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Crowley, T. C. Smith, Z. Fang, N. Takizawa, and E. J. Luna
Supervillin Reorganizes the Actin Cytoskeleton and Increases Invadopodial Efficiency
Mol. Biol. Cell,
February 1, 2009;
20(3):
948 - 962.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-J. Yu, T. Pisitkun, G. Wang, J. F. Aranda, P. A. Gonzales, D. Tchapyjnikov, R.-F. Shen, M. A. Alonso, and M. A. Knepper
Large-scale quantitative LC-MS/MS analysis of detergent-resistant membrane proteins from rat renal collecting duct
Am J Physiol Cell Physiol,
September 1, 2008;
295(3):
C661 - C678.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Zheng, J. Chu, Y. Qiu, H. H. Loh, and P.-Y. Law
Agonist-selective signaling is determined by the receptor location within the membrane domains
PNAS,
July 8, 2008;
105(27):
9421 - 9426.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Takizawa, R. Ikebe, M. Ikebe, and E. J. Luna
Supervillin slows cell spreading by facilitating myosin II activation at the cell periphery
J. Cell Sci.,
November 1, 2007;
120(21):
3792 - 3803.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Sun, C. R. Weber, A. Sohail, M. M. Bernardo, M. Toth, H. Zhao, J. R. Turner, and R. Fridman
MMP25 (MT6-MMP) Is Highly Expressed in Human Colon Cancer, Promotes Tumor Growth, and Exhibits Unique Biochemical Properties
J. Biol. Chem.,
July 27, 2007;
282(30):
21998 - 22010.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Dwir, V. Grabovsky, R. Pasvolsky, E. Manevich, R. Shamri, P. Gutwein, S. W. Feigelson, P. Altevogt, and R. Alon
Membranal Cholesterol Is Not Required for L-Selectin Adhesiveness in Primary Lymphocytes but Controls a Chemokine-Induced Destabilization of L-Selectin Rolling Adhesions
J. Immunol.,
July 15, 2007;
179(2):
1030 - 1038.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Hinzpeter, J. Fritsch, F. Borot, S. Trudel, D.-L. Vieu, F. Brouillard, M. Baudouin-Legros, J. Clain, A. Edelman, and M. Ollero
Membrane Cholesterol Content Modulates ClC-2 Gating and Sensitivity to Oxidative Stress
J. Biol. Chem.,
January 26, 2007;
282(4):
2423 - 2432.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Cuschieri, J. Billigren, and R. V. Maier
Endotoxin tolerance attenuates LPS-induced TLR4 mobilization to lipid rafts: a condition reversed by PKC activation
J. Leukoc. Biol.,
December 1, 2006;
80(6):
1289 - 1297.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. G. Sitrin, S. L. Emery, T. M. Sassanella, R. A. Blackwood, and H. R. Petty
Selective Localization of Recognition Complexes for Leukotriene B4 and Formyl-Met-Leu-Phe within Lipid Raft Microdomains of Human Polymorphonuclear Neutrophils
J. Immunol.,
December 1, 2006;
177(11):
8177 - 8184.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. Laliberte, L. W. McGinnes, M. E. Peeples, and T. G. Morrison
Integrity of membrane lipid rafts is necessary for the ordered assembly and release of infectious newcastle disease virus particles.
J. Virol.,
November 1, 2006;
80(21):
10652 - 10662.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. K. Klausen, C. Hougaard, E. K. Hoffmann, and S. F. Pedersen
Cholesterol modulates the volume-regulated anion current in Ehrlich-Lettre ascites cells via effects on Rho and F-actin
Am J Physiol Cell Physiol,
October 1, 2006;
291(4):
C757 - C771.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Morel, S. Claverol, S. Mongrand, F. Furt, J. Fromentin, J.-J. Bessoule, J.-P. Blein, and F. Simon-Plas
Proteomics of Plant Detergent-resistant Membranes
Mol. Cell. Proteomics,
August 1, 2006;
5(8):
1396 - 1411.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. T. Browman, M. E. Resek, L. D. Zajchowski, and S. M. Robbins
Erlin-1 and erlin-2 are novel members of the prohibitin family of proteins that define lipid-raft-like domains of the ER
J. Cell Sci.,
August 1, 2006;
119(15):
3149 - 3160.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Takizawa, T. C. Smith, T. Nebl, J. L. Crowley, S. J. Palmieri, L. M. Lifshitz, A. G. Ehrhardt, L. M. Hoffman, M. C. Beckerle, and E. J. Luna
Supervillin modulation of focal adhesions involving TRIP6/ZRP-1
J. Cell Biol.,
July 31, 2006;
174(3):
447 - 458.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Street, S. J. Marsh, P. R. Stabach, J. S. Morrow, D. A. Brown, and N. J. Buckley
Stimulation of G{alpha}q-coupled M1 muscarinic receptor causes reversible spectrin redistribution mediated by PLC, PKC and ROCK
J. Cell Sci.,
April 15, 2006;
119(8):
1528 - 1536.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. J. Byfield, S. Tikku, G. H. Rothblat, K. J. Gooch, and I. Levitan
OxLDL increases endothelial stiffness, force generation, and network formation
J. Lipid Res.,
April 1, 2006;
47(4):
715 - 723.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K.M. Kadam, S.J. D'Souza, A.H. Bandivdekar, and U. Natraj
Identification and characterization of oviductal glycoprotein-binding protein partner on gametes: epitopic similarity to non-muscle myosin IIA, MYH 9
Mol. Hum. Reprod.,
April 1, 2006;
12(4):
275 - 282.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Bodin and M. D. Welch
Plasma Membrane Organization Is Essential for Balancing Competing Pseudopod- and Uropod-promoting Signals during Neutrophil Polarization and Migration
Mol. Biol. Cell,
December 1, 2005;
16(12):
5773 - 5783.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Fabbri, S. Di Meglio, M. C. Gagliani, E. Consonni, R. Molteni, J. R. Bender, C. Tacchetti, and R. Pardi
Dynamic Partitioning into Lipid Rafts Controls the Endo-Exocytic Cycle of the {alpha}L/{beta}2 Integrin, LFA-1, during Leukocyte Chemotaxis
Mol. Biol. Cell,
December 1, 2005;
16(12):
5793 - 5803.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Lominadze, D. W. Powell, G. C. Luerman, A. J. Link, R. A. Ward, and K. R. McLeish
Proteomic Analysis of Human Neutrophil Granules
Mol. Cell. Proteomics,
October 1, 2005;
4(10):
1503 - 1521.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. F Meiri
Lipid rafts and regulation of the cytoskeleton during T cell activation
Phil Trans R Soc B,
September 29, 2005;
360(1461):
1663 - 1672.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Iida, T. Kohro, T. Kodama, S. Nagata, and R. Fukunaga
Identification of CCR2, flotillin, and gp49B genes as new G-CSF targets during neutrophilic differentiation
J. Leukoc. Biol.,
August 1, 2005;
78(2):
481 - 490.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. E. Mattila, C. E. Green, U. Schaff, S. I. Simon, and B. Walcheck
Cytoskeletal interactions regulate inducible L-selectin clustering
Am J Physiol Cell Physiol,
August 1, 2005;
289(2):
C323 - C332.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. C. Nicholson, M. Ayhan, N. J. Hoogenraad, and H. Zola
In silico evaluation of two mass spectrometry-based approaches for the identification of novel human leukocyte cell-surface proteins
J. Leukoc. Biol.,
February 1, 2005;
77(2):
190 - 198.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. H.H. Borner, D. J. Sherrier, T. Weimar, L. V. Michaelson, N. D. Hawkins, A. MacAskill, J. A. Napier, M. H. Beale, K. S. Lilley, and P. Dupree
Analysis of Detergent-Resistant Membranes in Arabidopsis. Evidence for Plasma Membrane Lipid Rafts
Plant Physiology,
January 1, 2005;
137(1):
104 - 116.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. P. Price, R. J. Thompson, J. O. Eshcol, J. A. Wemmie, and C. J. Benson
Stomatin Modulates Gating of Acid-sensing Ion Channels
J. Biol. Chem.,
December 17, 2004;
279(51):
53886 - 53891.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-L. Chou, B. M. Christensen, S. Frische, H. Vorum, R. A. Desai, J. D. Hoffert, P. de Lanerolle, S. Nielsen, and M. A. Knepper
Non-muscle Myosin II and Myosin Light Chain Kinase Are Downstream Targets for Vasopressin Signaling in the Renal Collecting Duct
J. Biol. Chem.,
November 19, 2004;
279(47):
49026 - 49035.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. R. Yan, D. M. Byers, and R. Bortolussi
Role of Protein Tyrosine Kinase p53/56lyn in Diminished Lipopolysaccharide Priming of Formylmethionylleucyl- phenylalanine-Induced Superoxide Production in Human Newborn Neutrophils
Infect. Immun.,
November 1, 2004;
72(11):
6455 - 6462.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Badizadegan, H. E. Wheeler, Y. Fujinaga, and W. I. Lencer
Trafficking of cholera toxin-ganglioside GM1 complex into Golgi and induction of toxicity depend on actin cytoskeleton
Am J Physiol Cell Physiol,
November 1, 2004;
287(5):
C1453 - C1462.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. D. X. Chuong, A. G. Good, G. J. Taylor, M. C. Freeman, G. B. G. Moorhead, and D. G. Muench
Large-scale Identification of Tubulin-binding Proteins Provides Insight on Subcellular Trafficking, Metabolic Channeling, and Signaling in Plant Cells
Mol. Cell. Proteomics,
October 1, 2004;
3(10):
970 - 983.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. S. Gangopadhyay, N. Takizawa, C. Gallant, A. L. Barber, H.-D. Je, T. C. Smith, E. J. Luna, and K. G. Morgan
Smooth muscle archvillin: a novel regulator of signaling and contractility in vascular smooth muscle
J. Cell Sci.,
October 1, 2004;
117(21):
5043 - 5057.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. B. Fessler, P. G. Arndt, S. C. Frasch, J. G. Lieber, C. A. Johnson, R. C. Murphy, J. A. Nick, D. L. Bratton, K. C. Malcolm, and G. S. Worthen
Lipid Rafts Regulate Lipopolysaccharide-induced Activation of Cdc42 and Inflammatory Functions of the Human Neutrophil
J. Biol. Chem.,
September 17, 2004;
279(38):
39989 - 39998.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Rayman, A. K. Wesa, A. L. Richmond, T. Das, K. Biswas, G. Raval, W. J. Storkus, C. Tannenbaum, A. Novick, R. Bukowski, et al.
Effect of Renal Cell Carcinomas on the Development of Type 1 T-Cell Responses
Clin. Cancer Res.,
September 15, 2004;
10(18):
6360S - 6366S.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. C. Laughlin, G. C. McGugan, R. R. Powell, B. H. Welter, and L. A. Temesvari
Involvement of Raft-Like Plasma Membrane Domains of Entamoeba histolytica in Pinocytosis and Adhesion
Infect. Immun.,
September 1, 2004;
72(9):
5349 - 5357.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Mongrand, J. Morel, J. Laroche, S. Claverol, J.-P. Carde, M.-A. Hartmann, M. Bonneu, F. Simon-Plas, R. Lessire, and J.-J. Bessoule
Lipid Rafts in Higher Plant Cells: PURIFICATION AND CHARACTERIZATION OF TRITON X-100-INSOLUBLE MICRODOMAINS FROM TOBACCO PLASMA MEMBRANE
J. Biol. Chem.,
August 27, 2004;
279(35):
36277 - 36286.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Whitsett, C. J. Bachurski, K. C. Barnes, P. A. Bunn Jr., L. M. Case, D. N. Cook, D. Crooks, M. W. Duncan, L. Dwyer-Nield, R. C. Elston, et al.
Functional Genomics of Lung Disease
Am. J. Respir. Cell Mol. Biol.,
August 1, 2004;
31(2/S1):
S1 - S81.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Cao, M. J. Cismowski, M. Sato, J. B. Blumer, and S. M. Lanier
Identification and Characterization of AGS4: A PROTEIN CONTAINING THREE G-PROTEIN REGULATORY MOTIFS THAT REGULATE THE ACTIVATION STATE OF Gi{alpha}
J. Biol. Chem.,
June 25, 2004;
279(26):
27567 - 27574.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Bhattacharya, P. J. Peters, and P. R. Clapham
Human Immunodeficiency Virus Type 1 Envelope Glycoproteins That Lack Cytoplasmic Domain Cysteines: Impact on Association with Membrane Lipid Rafts and Incorporation onto Budding Virus Particles
J. Virol.,
May 15, 2004;
78(10):
5500 - 5506.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Tyska and M. S. Mooseker
A role for myosin-1A in the localization of a brush border disaccharidase
J. Cell Biol.,
May 10, 2004;
165(3):
395 - 405.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. T. Stickney, W. C. Bacon, M. Rojas, N. Ratner, and W. Ip
Activation of the Tumor Suppressor Merlin Modulates Its Interaction with Lipid Rafts
Cancer Res.,
April 15, 2004;
64(8):
2717 - 2724.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Kumar, Y.-P. Xiao, P. J. Laipis, B. S. Fletcher, and S. C. Frost
Glucose deprivation enhances targeting of GLUT1 to lipid rafts in 3T3-L1 adipocytes
Am J Physiol Endocrinol Metab,
April 1, 2004;
286(4):
E568 - E576.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Gomez-Mouton, R. A. Lacalle, E. Mira, S. Jimenez-Baranda, D. F. Barber, A. C. Carrera, C. Martinez-A., and S. Manes
Dynamic redistribution of raft domains as an organizing platform for signaling during cell chemotaxis
J. Cell Biol.,
March 1, 2004;
164(5):
759 - 768.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. C. Murphy, B. U. Samuel, T. Harrison, K. D. Speicher, D. W. Speicher, M. E. Reid, R. Prohaska, P. S. Low, M. J. Tanner, N. Mohandas, et al.
Erythrocyte detergent-resistant membrane proteins: their characterization and selective uptake during malarial infection
Blood,
March 1, 2004;
103(5):
1920 - 1928.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Dolganiuc, L. McGinnes, E. J. Luna, and T. G. Morrison
Role of the Cytoplasmic Domain of the Newcastle Disease Virus Fusion Protein in Association with Lipid Rafts
J. Virol.,
December 15, 2003;
77(24):
12968 - 12979.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Chen, N. Takizawa, J. L. Crowley, S. W. Oh, C. L. Gatto, T. Kambara, O. Sato, X.-d. Li, M. Ikebe, and E. J. Luna
F-actin and Myosin II Binding Domains in Supervillin
J. Biol. Chem.,
November 14, 2003;
278(46):
46094 - 46106.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Hixon and K. Boekelheide
Expression and Localization of Total Akt1 and Phosphorylated Akt1 in the Rat Seminiferous Epithelium
J Androl,
November 1, 2003;
24(6):
891 - 898.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. S. Heinemann, G. Korza, and J. Ozols
A Plasminogen-like Protein Selectively Degrades Stearoyl-CoA Desaturase in Liver Microsomes
J. Biol. Chem.,
October 31, 2003;
278(44):
42966 - 42975.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Boilard, S. G. Bourgoin, C. Bernatchez, and M. E. Surette
Identification of an autoantigen on the surface of apoptotic human T cells as a new protein interacting with inflammatory group IIA phospholipase A2
Blood,
October 15, 2003;
102(8):
2901 - 2909.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. David, Y. Kacher, U. Specks, and I. Aviram
Interaction of proteinase 3 with CD11b/CD18 ({beta}2integrin) on the cell membrane of human neutrophils
J. Leukoc. Biol.,
October 1, 2003;
74(4):
551 - 557.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. B. Marta, C. M. Taylor, T. Coetzee, T. Kim, S. Winkler, R. Bansal, and S. E. Pfeiffer
Antibody Cross-Linking of Myelin Oligodendrocyte Glycoprotein Leads to Its Rapid Repartitioning into Detergent-Insoluble Fractions, and Altered Protein Phosphorylation and Cell Morphology
J. Neurosci.,
July 2, 2003;
23(13):
5461 - 5471.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. W. Oh, R. K. Pope, K. P. Smith, J. L. Crowley, T. Nebl, J. B. Lawrence, and E. J. Luna
Archvillin, a muscle-specific isoform of supervillin, is an early expressed component of the costameric membrane skeleton
J. Cell Sci.,
June 1, 2003;
116(11):
2261 - 2275.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|